Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment.

Diabetes Obes Metab · 2017 · PMC5655920 · PMID 28449324

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Body weight loss was also observed in the moderate renal impairment category, but this did not reach statistical significance. 3.3.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.